High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  New England Journal of Medicine

• Publication date

  1997-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1056/NEJM199705013361803PMID 9113931
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparative and experimental pathology of fibrosing colonopathy.

  1996cited by this paper
• Colonic strictures in patients with cystic fibrosis: results of a survey of 114 cystic fibrosis care centers in the United States.

  1996cited by this paper
• Diffuse fibrosis of the colon complicating cystic fibrosis.

  1996cited by this paper
• Fibrosing colonopathy in cystic fibrosis: results of a case-control study.

  1995cited by this paper
• Colonic strictures in children with cystic fibrosis on low-strength pancreatic enzymes.

  1995cited by this paper
• Dose‐Response and Trend Analysis in Epidemiology: Alternatives to Categorical Analysis

  1995cited by this paper
• Gut inflammation in children with cystic fibrosis on high-dose enzyme supplements.

  1995cited by this paper
• Colonic strictures in children with cystic fibrosis.

  1995cited by this paper
• Use of pancreatic enzyme supplements for patients with cystic fibrosis in the context of fibrosing colonopathy. Consensus Committee.

  1995cited by this paper
• Cystic fibrosis and colonic strictures. A new "iatrogenic" disease.

  1995cited by this paper
• Cystic fibrosis-associated colitis and fibrosing colonopathy.

  1995cited by this paper
• Fibrosing colonopathy in a child on low-dose pancreatin.

  1995cited by this paper
• Relation of thickening of colon wall to pancreatic-enzyme treatment in cystic fibrosis.

  1995cited by this paper
• The catheter ghost syndrome.

  1994cited by this paper
• Pancolonic disease in cystic fibrosis and high-dose pancreatic enzyme therapy.

  1994cited by this paper
• High-strength pancreatic enzymes.

  1994cited by this paper
• Strictures of ascending colon in cystic fibrosis and high-strength pancreatic enzymes.

  1994cited by this paper
• High-strength pancreatic enzyme supplements and large-bowel stricture in cystic fibrosis.

  1994cited by this paper
• Extensive pathological changes of the colon in cystic fibrosis and high-strength pancreatic enzymes.

  1994cited by this paper
• High-strength pancreatic enzymes.

  1994cited by this paper
• High-strength pancreatic enzyme supplements and large-bowel stricture in cystic fibrosis.

  1994cited by this paper
• High-strength pancreatic enzymes.

  1994cited by this paper
• High strength pancreatic exocrine enzyme capsules associated with colonic strictures in patients with cystic fibrosis: "more is not necessarily better".

  1994cited by this paper
• High-strength pancreatic enzymes.

  1994cited by this paper
• The changing epidemiology of cystic fibrosis.

  1993cited by this paper

• Validation of dietary whey protein substrate challenge absorption test as an indicator of proteolysis

  2025cites this paper
• Pediatric Pulmonology

  2025cites this paper
• Gastrointestinal challenges in nephropathic cystinosis: clinical perspectives

  2024cites this paper
• Pancreas and pancreatitis: Exocrine pancreatic insufficiency

  2024cites this paper
• EVALUATING LACTOFERRIN AND CALPROTECTIN AS MARKERS OF INTESTINAL INFLAMMATION INCHRONIC PANCREATITIS.

  2024cites this paper
• Comparative Investigation of pH–Dependent Availability of Pancreatic Enzyme Preparations In Vitro

  2024cites this paper
• Exocrine pancreatic insufficiency and pancreatic exocrine replacement therapy in clinical practice.

  2024cites this paper
• Cystic fibrosis and fat malabsorption: Pathophysiology of the cystic fibrosis gastrointestinal tract and the impact of highly effective CFTR modulator therapy.

  2024cites this paper
• Pancreatitis in cystic fibrosis: Presentation, medical and surgical management, and the impact of modulator therapies

  2024cites this paper
• Porcine-derived pancreatic enzyme replacement therapy may be linked to chronic hepatitis E virus infection in cystic fibrosis lung transplant recipients

  2024cites this paper
• Rational Prescribing of Pancreatic Enzymes for Patients with Pancreatic Cancer

  2024cites this paper
• European guidelines for the diagnosis and treatment of pancreatic exocrine insufficiency: UEG, EPC, EDS, ESPEN, ESPGHAN, ESDO, and ESPCG evidence‐based recommendations

  2024influential citation
• Fibrosing colonopathy associated with cysteamine bitartrate delayed-release capsules in cystinosis patients

  2024cites this paper
• Current and Future Therapeutic Approaches of Exocrine Pancreatic Insufficiency in Children with Cystic Fibrosis in the Era of Personalized Medicine

  2023cites this paper
• Clinical and Imaging Features of Cystic Fibrosis in Korean Children

  2023cites this paper
• Cystic Fibrosis-Associated Gastrointestinal Disease in Neonates.

  2023cites this paper
• Exocrine Pancreatic Insufficiency in Children – Challenges in Management

  2023cites this paper
• A Gastroenterologist’s Guide to Care Transitions in Cystic Fibrosis from Pediatrics to Adult Care

  2023cites this paper
• Nutrition support in the pediatric total pancreatectomy with islet autotransplantation recipient.

  2023cites this paper
• Fibrosing Colonopathy Presenting in a Patient with Cystinosis

  2023cites this paper
• ESPEN practical guideline on clinical nutrition in acute and chronic pancreatitis.

  2023cites this paper
• Incidence of fibrosing colonopathy with pancreatic enzyme replacement therapy in patients with cystic fibrosis.

  2023cites this paper
• Pancreatic Enzyme Replacement Therapy in Cystic Fibrosis

  2022cites this paper
• AGA-PancreasFest Joint Symposium on Exocrine Pancreatic Insufficiency

  2022cites this paper
• Nutritional Therapy, Pancreatic Exocrine Insufficiency, and Pancreatic Enzyme Replacement Therapy in Cystic Fibrosis

  2021cites this paper
• Cystic Fibrosis and Congenital Anomalies of the Exocrine Pancreas

  2021cites this paper
• Cystic Fibrosis—Diagnosis, Genetics and Lifelong Effects

  2021cites this paper
• Recent advances in the early treatment of cystic fibrosis: Bridging the gap to highly effective modulator therapy

  2021cites this paper
• Mimics of Inflammatory Bowel Disease

  2020cites this paper
• ESPEN guideline on clinical nutrition in acute and chronic pancreatitis.

  2020cites this paper
• Coeliac Disease

  2020cites this paper
• Inflammatory Bowel Disease Diagnosis

  2020cites this paper
• Pancreatic exocrine insufficiency after pancreaticoduodenectomy: Current evidence and management

  2020cites this paper
• Changing paradigms in the treatment of gastrointestinal complications of cystic fibrosis in the era of cystic fibrosis transmembrane conductance regulator modulators.

  2020cites this paper
• Cystic Fibrosis: A Multi-Organ System Approach

  2020cites this paper
• Gastrointestinal Ischemia and Vascular Disorders

  2020cites this paper
• Ileal Pouch Anal Anastomosis

  2020cites this paper
• Histology of Gastroesophageal Reflux Disease and Barrett’s Oesophagus

  2020cites this paper
• Nutrition and gastrointestinal disorders

  2020cites this paper
• Diverticular Disease, Mucosal Prolapse, and Related Conditions

  2020cites this paper
• The Value of Gastrointestinal Biopsy

  2020cites this paper
• Transplantation, Immunodeficiency, and Immunosuppression

  2020cites this paper
• Normal Lower Gastrointestinal Mucosa

  2020cites this paper
• Gastrointestinal Complications

  2020cites this paper
• Infections of the Oesophagus and Rare Forms of Oesophagitis

  2020cites this paper
• Inflammatory Bowel Disease and the Upper Gastrointestinal Tract

  2020cites this paper
• Pancreatic Enzymes

  2020cites this paper
• Abdominelle Manifestationen bei Mukoviszidose

  2020cites this paper
• Preface

  2020cites this paper
• Drug-Induced Gastrointestinal Disease

  2020cites this paper
• Inflammatory bowel disease–like conditions: medication-induced enteropathy

  2020cites this paper
• Gastrointestinal Involvement by Systemic Disease

  2020cites this paper
• Radiation and the Gastrointestinal Tract

  2020cites this paper
• Index

  2020cites this paper
• Microscopic Colitis

  2020cites this paper
• Approach to Reporting Inflammatory Bowel Disease Biopsies

  2020cites this paper
• Assessment of Gastric Biopsies

  2020cites this paper
• Gastrointestinal Dysplasia

  2020cites this paper
• Types of Gastritis

  2020cites this paper
• Non-Neoplastic Diseases of the Anal Canal

  2020cites this paper
• Non-Neoplastic Pathology of the Gastrointestinal Tract

  2020cites this paper
• Jejunitis and Ileitis

  2020cites this paper
• Exocrine Pancreatic Insufficiency and Nutritional Complications

  2020cites this paper
• Duodenitis

  2020cites this paper
• Paediatric Conditions

  2020cites this paper
• Complications of Inflammatory Bowel Disease

  2020cites this paper
• Neonatal Surgery

  2020influential citation
• Infectious Disorders of the Lower Gastrointestinal Tract

  2020cites this paper
• Normal Oesophageal, Gastric and Duodenal Mucosa

  2020cites this paper
• Chronic Pancreatitis and Nutrition Therapy.

  2019cites this paper
• Nonpulmonary Manifestations of Cystic Fibrosis

  2019cites this paper
• Gastrointestinal and Hepatobiliary Disease in Cystic Fibrosis

  2019cites this paper
• Meconium Ileus

  2019cites this paper
• Severe ileocecal inflammatory syndrome in adult patients with cystic fibrosis

  2019cites this paper
• Up-To-Date View on the Clinical Manifestations and Complications of Chronic Pancreatitis

  2019cites this paper
• Nutrition in cystic fibrosis: From the past to the present and into the future

  2019cites this paper
• Growth and Nutrition in Cystic Fibrosis

  2019cites this paper
• Prevention of drug-related complications in cystic fibrosis.

  2019cites this paper
• Management of Exocrine Pancreatic Insufficiency in Children.

  2019cites this paper
• Relationship of Initial Pancreatic Enzyme Replacement Therapy Dose With Weight Gain in Infants With Cystic Fibrosis

  2018cites this paper
• Nutritional support and therapy in pancreatic surgery: A position paper of the International Study Group on Pancreatic Surgery (ISGPS)

  2018cites this paper
• Challenges in the management of pancreatic exocrine insufficiency

  2018cites this paper
• Meconium Ileus

  2018cites this paper
• Diagnosis and management of pancreatic exocrine insufficiency (PEI) in primary care: consensus guidance of a Canadian expert panel

  2018cites this paper
• Approach to chronic abdominal pain in Cystic Fibrosis.

  2017cites this paper
• The use of assisted autogenic drainage in children with acute and chronic respiratory disease

  2017cites this paper
• Practical guide to exocrine pancreatic insufficiency – Breaking the myths

  2017cites this paper
• 2 Radiological Features of Cystic Fibrosis

  2017cites this paper
• Pancreatic Enzyme Replacement Therapy Use in Infants With Cystic Fibrosis Diagnosed by Newborn Screening

  2017cites this paper
• Distal intestinal obstruction syndrome and colonic pathologies in cystic fibrosis.

  2017cites this paper
• The economic consequences of the introduction of Creon Micro into the basal therapy of exocrine pancreas deficiency due to cystic fibrosis in the children presenting with mucoviscidosis

  2017cites this paper
• Variables associated with loss of ileoanal pouches constructed in childhood.

  2017cites this paper
• Pancreatic insufficiency in Cystic Fibrosis.

  2017cites this paper
• Less common etiologies of exocrine pancreatic insufficiency

  2017cites this paper
• Small Bowel Ultrasound beyond Inflammatory Bowel Disease: An Updated Review of the Recent Literature.

  2017cites this paper
• Nutrition and Cystic Fibrosis

  2017cites this paper
• Comparison of two pancreatic enzyme products for exocrine insufficiency in patients with cystic fibrosis.

  2016cites this paper
• Gastrointestinal Disorders in Cystic Fibrosis.

  2016cites this paper
• Cystic fibrosis: April 2016

  2016cites this paper
• Facing Terminal Ileitis: Going Beyond Crohn’s Disease

  2016cites this paper